Clinical Trials Program News Today

Medical marijuana. I heard something in that area about it endo cannabinoid system that is unique to mammals and therefore we have some kind of receptors. Is that on anybodys, how are we doing on that apartment against propaganda . Guest they always have receptors in our break for every issue their something new and exciting. I think the timeframe is accelerating. We are doing two things. I dont want to take up too much time but with converting some cancers into chronic diseases, the best exampl...

Reprieve Cardiovascular partners with leading heart failure researchers and Truveta to analyze real-world heart failure patient data to highlight opportunities to improve the current patient management paradigm

Content Click below to navigate through the document Welcome Novartis proposal for the...

Jaime R. Merchán, MD, discusses the current roles for immunotherapy and TKIs in patients with renal cell carcinoma.

Jaime R. Merchán, MD, discusses the role of pembrolizumab plus axitinib or lenvatinib in previously untreated advanced renal cell carcinoma.

Statistically Significant and Clinically Meaningful Increasein Primary Efficacy Endpoint at 24 Weeks of Treatment; Improvement Consistent Across All Prespecified Subgroups Statistically Significant...

FIGARO-BM, an exploratory human biomarker study, provides additional insight on finerenone's mechanism of action in blocking mineralocorticoid receptor (MR) overactivation1New data presented at the American Society of Nephrology’s (ASN) Kidney Week 2023WHIPPANY, N.J.--(BUSINESS WIRE)--At the American Society of Neph...

WHIPPANY, N.J.--(BUSINESS WIRE)--Nov 2, 2023--

/PRNewswire/ -- Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance, is proud to share that the successful results of the...

New Long-Term Data from FOREST-HCM, the Open-Label Extension Study of Aficamten,Show Sustained Improvements in Clinical Efficacy Endpointsand No Treatment Interruptions for Low Ejection Fraction ...